NeOnc Technologies Holdings (NTHI) reported second-quarter 2026 financial results and confirmed it will present topline Phase 2a NEO100 data on August 12, 2026.
The clinical-stage biopharmaceutical company reported a net loss of $14.2 million, or $0.58 per diluted share, for the quarter ended June 30, 2026. Research and development expenses rose to $2.6 million, while general and administrative expenses declined to $0.9 million.
- Cash and cash equivalents were approximately $2.0 million as of June 30, 2026.
- The company maintained an undrawn $10.0 million line of credit with HCWG.
- NeOnc received UAE IND approvals for NEO100 and NEO212 in June.
- The company completed topline analysis of its fully enrolled Phase 2a NEO100 study in recurrent IDH1-mutant high-grade glioma.
- An investor call and webcast is scheduled for August 12, 2026, with webcast access at webcaster5.com.
$NTHI Insider Trading Activity
$NTHI insiders have traded $NTHI stock on the open market 10 times in the past 6 months. Of those trades, 10 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $NTHI stock by insiders over the last 6 months:
- AMIR F HESHMATPOUR (President) has made 8 purchases buying 80,000 shares for an estimated $420,120 and 0 sales.
- YOUSHA NEMAN-EBRAHIM (Chief Clinical Officer) purchased 500 shares for an estimated $2,440
- DAVID JR. SUH, (Chief Accounting Officer) purchased 200 shares for an estimated $1,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$NTHI Hedge Fund Activity
We have seen 13 institutional investors add shares of $NTHI stock to their portfolio, and 10 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CINCTIVE CAPITAL MANAGEMENT LP added 1,425,526 shares (+inf%) to their portfolio in Q1 2026, for an estimated $9,992,937
- HIGHPOINT ADVISOR GROUP LLC removed 1,144,640 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $8,023,926
- WESTMOUNT PARTNERS, LLC added 153,858 shares (+355.2%) to their portfolio in Q2 2026, for an estimated $696,976
- HUDSON BAY CAPITAL MANAGEMENT LP added 147,360 shares (+inf%) to their portfolio in Q1 2026, for an estimated $1,032,993
- MILLENNIUM MANAGEMENT LLC added 119,249 shares (+inf%) to their portfolio in Q1 2026, for an estimated $835,935
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 91,036 shares (+inf%) to their portfolio in Q1 2026, for an estimated $638,162
- MORGAN STANLEY added 43,718 shares (+532.9%) to their portfolio in Q1 2026, for an estimated $306,463
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
